Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

IMCgp-100 well tolerated in patients with advanced melanoma

April 18, 2013

Clinical data for AMP-224 presented at AACR meeting

April 18, 2013

Peptide-based anticancer vaccine J-65 induces tumor cell lysis

April 15, 2013

Amorfix Life Sciences reveals latest tumor study findings

April 11, 2013

Preclinical development of an anticancer antibody with a unique mechanism of action

April 11, 2013

Bavarian Nordic plans interim analysis of PROSPECT trial

April 10, 2013

Dainippon Sumitomo and Chugai agree to terminate joint development of anticancer vaccine candidates

April 9, 2013

Alligator Bioscience and BioInvent International design new antibodies for cancer

April 5, 2013

Imperial Innovations researchers describe anti-DDR1 antibodies

April 4, 2013

Daratumumab granted FDA fast track designation

April 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...